News & Videos - PHIBRO ANIMAL HEALTH - Page 2

Phibro Animal Health Corporation (Nasdaq: PAHC) today announced financial results for its third quarter ended March 31, 2022. Highlights for the three months ended March 31, 2022 (compared to the three months ended March 31, 2021) Net sales of $239.6 million, an increase of $27.9 million, or 13% Net income of $17.7 million, an increase of $5.5 million, or 45% Diluted EPS of $0.44, an increase of $0.14 or 47% Adjusted EBITDA of $28.0 million, comparable to the prior year Adjusted Net Income of...

The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on June 22, 2022, to stockholders of record at the close of business on June 1, 2022. About Phibro Animal Health Corporation Phibro Animal Health Corporation is a diversified global developer, manufacturer and supplier of a broad range of animal health and mineral nutrition products for livestock,...

Phibro Animal Health Corporation (Nasdaq:PAHC) expects to announce its third quarter financial results on Wednesday, May 4, 2022, after the market closes. Phibro management will host a conference call and webcast on Thursday, May 5, 2022, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com . The discussion will also be available by dialing +1 (888) 330-2022 in the U.S. and Canada, or +1...

Phibro Animal Health Corporation (NASDAQ:PAHC) announced today that it will participate in the Barclays Global Healthcare Conference being held at the Loews Miami Beach Hotel in Miami Beach, Florida. Chief Financial Officer Damian Finio will address financial analysts and investors on Tuesday, March 15, 2022, at 8:00 AM ET. The live audio presentation will be available on the Phibro Animal Health Corporation Investor Relations Website at https://investors.pahc.com . A replay of the session will...

Phibro Animal Health Corporation (Nasdaq:PAHC) today announced financial results for its second quarter ended December 31, 2021. Highlights for the three months ended December 31, 2021 (compared to the three months ended December 31, 2020) Net sales of $233 million, an increase of $27 million, or 13% Net income of $17 million, an increase of $5 million, or 36% Diluted EPS of $0.43, an increase of $0.11 or 34% Adjusted EBITDA of $29 million, an increase of $1 million, or 2% Adjusted Net Income of...

The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on March 23, 2022, to stockholders of record at the close of business on March 2, 2022. About Phibro Animal Health Corporation Phibro Animal Health Corporation is a diversified global developer, manufacturer and supplier of a broad range of animal health and mineral nutrition products for livestock,...

Phibro Animal Health Corporation (NASDAQ:PAHC) announced today that it will participate in the BofA Securities 2022 Virtual Animal Health Summit. Chief Financial Officer Damian Finio and Executive Vice President, Corporate Strategy Daniel Bendheim will address financial analysts and investors on Thursday, February 24, 2022, at 12:40 PM ET. The live audio presentation will be available on the Phibro Animal Health Corporation Investor Relations Website at https://investors.pahc.com . A replay of...

Phibro Animal Health Corporation (NASDAQ:PAHC): Today, the Food and Drug Administration (FDA) provided notice in the Federal Register of its intention to hold a public hearing regarding Mecadox ® (carbadox). Mecadox has been approved and sold in the United States for 50 years and is a widely used treatment for controlling bacterial diseases in swine, including Salmonella and swine dysentery, resulting in improved health and welfare for newly born and young pigs. The hearing will be hosted by...

Phibro Animal Health Corporation (Nasdaq:PAHC) expects to announce its second quarter financial results on Wednesday, February 9, 2022, after the market closes. Phibro management will host a conference call and webcast on Thursday, February 10, 2022, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com . The discussion will also be available by dialing +1 (888) 330-2022 in the U.S. and...

Phibro Animal Health Corporation (NASDAQ:PAHC) announced today that it will participate in the 4 th Annual Evercore ISI Virtual Conference. Chief Financial Officer Damian Finio and Executive Vice President, Corporate Strategy Daniel Bendheim will address financial analysts and investors on Wednesday, December 1, 2021, at 8:00 AM ET. The live audio presentation will be available on the Phibro Animal Health Corporation Investor Relations Website at https://investors.pahc.com . A replay of the...

Phibro Animal Health Corporation (Nasdaq:PAHC) today announced financial results for its first quarter ended September 30, 2021. Highlights for the three months ended September 30, 2021 (compared to the three months ended September 30, 2020) Net sales of $215 million, an increase of $20 million, or 10% Net income of $7 million, a decrease of $6 million, or 47% Diluted EPS of $0.16, a decrease of $0.14, or 47% Adjusted EBITDA of $22 million, a decrease of $2 million, or 8% Adjusted net income of...

The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on December 15, 2021, to stockholders of record at the close of business on November 24, 2021. About Phibro Animal Health Corporation Phibro Animal Health Corporation is a diversified global developer, manufacturer and supplier of a broad range of animal health and mineral nutrition products for...

Phibro Animal Health Corporation (Nasdaq:PAHC) expects to announce its first quarter financial results on Tuesday, November 2, 2021, after the market closes. Phibro management will host a conference call and webcast on Wednesday, November 3, 2021, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com . The discussion will also be available by dialing +1 (888) 330-2022 in the U.S. and...

Phibro Animal Health Corporation (NASDAQ:PAHC) announced today it will participate in the 30 th Annual Credit Suisse Virtual Healthcare Conference. Chairman, President and Chief Executive Officer Jack Bendheim, Chief Financial Officer Damian Finio and Executive Vice President, Corporate Strategy Daniel Bendheim will address financial analysts and investors on Tuesday, November 9, 2021, at 4:20 PM ET. The live audio presentation will be available on the Phibro Animal Health Corporation Investor...

Phibro Animal Health Corporation (Nasdaq:PAHC) today announced financial results for its fourth quarter and fiscal year ended June 30, 2021, and provided financial guidance for the year ending June 30, 2022. Highlights for the three months ended June 30, 2021 (compared to the three months ended June 30, 2020) Net sales of $220 million, an increase of $34 million, or 19% Net income of $17 million, an increase of $12 million, or 203% Diluted EPS of $0.42, an increase of $0.28, or 200% Adjusted...

Phibro Animal Health Corporation (Nasdaq:PAHC) announced today it will participate in the Bank of America Virtual Global Healthcare Conference. Chief Financial Officer Damian Finio will address financial analysts and investors on Wednesday, September 15, 2021 at 9:10 AM ET. The live audio presentation will be available on the Phibro Animal Health Corporation Investor Relations Website at https://investors.pahc.com . A replay of the session will be available and archived on the company’s...

Phibro Animal Health Corporation (Nasdaq:PAHC) expects to announce its fourth quarter and fiscal year 2021 financial results on Wednesday, August 25, 2021, after the market closes. Phibro management will host a conference call and webcast on Thursday, August 26, 2021, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com . The discussion will also be available by dialing +1 (833) 968-1955...

The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on September 22, 2021, to stockholders of record at the close of business on September 1, 2021. About Phibro Animal Health Corporation Phibro Animal Health Corporation is a diversified global developer, manufacturer and supplier of a broad range of animal health and mineral nutrition products for...

Phibro Animal Health Corporation (NASDAQ:PAHC) today announced financial results for its third quarter and year-to-date period ended March 31, 2021. Highlights for the March 31, 2021 quarter (compared to the quarter ended March 31, 2020) Net sales of $212 million, an increase of $1 million, or less than 1% Net income of $12 million, a decrease of $1 million, or 10% Diluted EPS of $0.30, a decrease of $0.03, or 9% Adjusted EBITDA of $28 million, a decrease of $2 million, or 7% Adjusted Net Income...

The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on June 23, 2021, to stockholders of record at the close of business on June 2, 2021. About Phibro Animal Health Corporation Phibro Animal Health Corporation is a diversified global developer, manufacturer and supplier of a broad range of animal health and mineral nutrition products for livestock,...